Pelthos Therapeutics, Inc. (PTHS)
24.20
-0.83
(-3.32%)
USD |
NYAM |
Dec 11, 15:20
Pelthos Therapeutics Market Cap: 15.96M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals, Inc. | 3.621B |
| Agenus, Inc. | 138.75M |
| Protalix Biotherapeutics, Inc. | 146.77M |
| Travere Therapeutics, Inc. | 3.115B |
| Genprex, Inc. | 3.274M |
Market Cap Related Metrics
| PS Ratio | 8.257 |
| PEG Ratio | -0.0023 |
| Price to Book Value | 0.2740 |
| Price | 24.20 |
| Earnings Yield | -58.65% |
| PEGY Ratio | -0.0023 |